RIPK1 and Alzheimer disease: Elevated CH25H expression has been observed in RIPK1-dependent pathways in AD mouse models and aging microglia, highlighting a novel connection between necroptosis and altered lipid metabolism in AD (Ofengeim et al., 2017; Mifflin et al., 2020).